Lung Cancer Clinical Trial
Functional Lung Imaging With DECT and 4DCT
Summary
The basic premise of this pilot study is to enroll 40 patients over 1.5 years who have Stage III or IV non-small cell lung cancer and are planned for definitive treatment with concurrent chemoradiation where a contrast enhanced 4DCT is planned..
Eligibility Criteria
Inclusion criteria:
Patients have histologic diagnosis of non-small cell lung cancer
Patients have AJCC stage III or IV disease were the plan is to receive definitive concurrent chemoradiation to 60 Gy or higher
Age > 18 years of age
Patients are able to provide informed consent
No additional lung radiation is planned until after the 2nd CT on this study (i.e. patient does not have a solitary pulmonary nodule or second primary that the plan is to undergo SBRT)
Patient must have adequate kidney function to receive IV contrast (following institutional policy supplied by radiology). The cutoff level for serum creatinine is 1.6 mg/dL
Negative urine pregnancy test before every CT scan
Exclusion criteria:
Allergy to IV iodine contrast
Severe claustrophobia
Further thoracic radiation therapy is planned.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19104, United States More Info
Principal Investigator
How clear is this clinincal trial information?